Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions. The news from the National Institutes of Health should provide some relief to...
The new Certificate in Stem Cell Techniques launched this fall at Madison Area Technical College (MATC) provides advanced-degree training in practical laboratory courses. It is thought to be the first course of its kind offered by a traditional two-year college. “This really makes sense in...
The FBI recently approved the Promega PowerPlex® 16 HS System for use by laboratories participating in, or generating DNA records for, the National DNA Index System (NDIS). NDIS currently contains more than seven million profiles and has assisted in over 94,000 investigations. It is populated...
Exact Sciences Corp. President and CEO Kevin T. Conroy turns his attention from the Governor's office to leading the Madison company to launch an early screening device for colon cancer. Conroy spoke recently about steering the company toward clinical trial for the yet unnamed test....
Today at the White House, President Obama launched the “Educate to Innovate” campaign, a nationwide effort includes over $260 million in public-private investments to move American students to the top of the pack in science and math achievement over the next decade President Obama...
Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure. Chronic heart failure is an increasingly important health problem. It is the leading medical cause of...
The NY Times reported today on how the concept of shared; low cost supercomputers are being paired with high performance computers from companies with strong Wisconsin Roots including as Cray and Silicon Graphics. The story revealed how users and developers of supercomputer users are using...
The first half of 2009 showed the tough road biotech, and other industries, had to hoe in order to survive. Earlier forecast this year were that many biotech companies would fail, go under, be delisted from the different exchanges, or barely hang on. But like...
Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. The study included 35 patients who received CD 133+...
The University of Wisconsin-Madison has received a five-year, $9.5 million grant from the Bill and Melinda Gates Foundation to identify virus mutations that would serve as early warnings of potential pandemic influenza viruses....